Meeting
2024 ASCO Annual Meeting
AMH levels after initial cycles of chemotherapy in female adolescents with Ewing sarcoma and implications for preservation of fertility.
Authors
Jie Xu
Peking University People’s Hospital, Beijing, China
Jie Xu , Xin Sun , Kuisheng Liu , Lu Xie , Jingtian Shi , Xiaodong Tang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Survivorship
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 10067)
DOI
10.1200/JCO.2024.42.16_suppl.10067
Abstract #
10067
Poster Bd #
434
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Dose intensity and outcomes of VDC/IE chemotherapy for adolescent and adult patients with Ewing’s family sarcoma.
First Author: Danielle Klingberg
Poster
2024 ASCO Breakthrough
Systemic treatment post curative-intent intervention based on tumor-informed circulating tumor DNA result for oligometastatic colorectal cancer.
First Author: Teerada Siripoon
Poster
2024 ASCO Annual Meeting
Primary intracranial germ cell tumors in adolescents and adults: Results of an international, multicenter, retrospective cohort study.
First Author: Stefanie Zschaebitz
Poster
2023 ASCO Annual Meeting
Response-adapted therapy (tx) with nivolumab plus brentuximab vedotin (nivo + BV) without autologous hematopoietic cell transplantation (auto-HCT) in children, adolescents, and young adults (CAYA) with low-risk relapsed/refractory (R/R) classic Hodgkin lymphoma (cHL): CheckMate 744.
First Author: Paul David Harker-Murray